La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Nutriband a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Nutriband..

Nutriband (NASDAQ:NTRB) Azioni, Catena delle Opzioni

Nutriband

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Nutriband Inc

As of Nov. 22, 2024, two stocks in the financials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">TowneBank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOWN#NASDAQ">TOWN</a>)</h3>
<ul>
<li>On Oct. 23, Towne Bank reported worse-than-expected third-quarter revenue. &#8220;Our third quarter results continued to deliver increased net interest income and noninterest income contributions from our diverse business model which were in line with expectations. We remain committed to prudent balance sheet management strategies. We were also excited to announce our partnership with Village Bank which will meaningfully enhance our Richmond presence, which is core to our franchise future growth. Lastly, the recently released FDIC Deposit Market Share Report for 2024 continues to demonstrate the strength of our Main Street banking model and core deposit franchise, resulting in the #1 market share, or 30%, in our legacy Virginia Beach-Norfolk-Newport News, VA-NC MSA,&#8221; said G. Robert Aston, Jr., Executive Chairman.</li>
<li>The company's stock gained around 32% over the past month and has a <a href="https://www.benzinga.com/quote/TOWN">52-week high of $36.67</a>.</li>
<li>RSI Value: 75.55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>TOWN Price Action: Shares of TowneBank gained 1.2% to close at $35.31 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Wisdomtree Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>)</h3>
<ul>
<li>On Oct. 25, WisdomTree posted upbeat quarterly results. &#8220;Our strong third-quarter results demonstrate how we are capitalizing on key secular growth trends, such as the expansion of our models business and our leadership in tokenization. As demand for efficient portfolio solutions continues to grow, we are broadening our reach in the advisor space while positioning ourselves at the forefront of blockchain-enabled finance. Platforms like WisdomTree Prime&#xAE; and WisdomTree Connect&#x2122; are integral to our future growth strategy, offering innovative solutions that meet the evolving needs of both retail and institutional clients. We believe these initiatives will drive substantial long-term value for our stakeholders.&#8221;</li>
<li>The company's stock gained around 12% over the past month and <a href="https://www.benzinga.com/quote/FRPT">has a 52-week high</a> of $12.14.</li>
<li>RSI Value: 79.49</li>
<li>WT Price Action: Shares of Wisdomtree gained 2.3% to close at $12.00 on Thursday.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42131399/dow-surges-over-450-points-investor-sentiment-improves-fear-greed-index-moves-to-greed-zone">Dow Surges Over 450 Points As Nvidia Climbs Post-Earnings, Google, Amazon Slip: Fear Index Shifts To &#8216;Greed&#8217; Zone</a></li>
</ul>

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

TOWN

Top 2 Financials Stocks That May Fall Off A Cliff This Quarter

Seaport Global analyst Glenn Chin upgrades Sonic Automotive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>) from Neutral to Buy and announces $74 price target.

Upgrades

Price Target

Analyst Ratings

Seaport Global Upgrades Sonic Automotive to Buy, Announces $74 Price Target

Blue Bird Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>) will release earnings results for its fourth quarter, after the <a href="https://www.benzinga.com/quote/BLBD/earnings">closing bell on Monday, Nov. 25.</a>
Analysts expect the Macon, Georgia-based bank to report quarterly earnings at 65 cents per share, down from 66 cents per share in the year-ago period. Blue Bird projects to report revenue of $343.95 million for the recent quarter, compared to $302.96 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Oct. 28, Blue Bird named Edward Hightower to its Board of Directors.
Blue Bird shares gained 2% to close at $40.08 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/BLBD/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5804a545846faa000106aa10/gregory-lewis">BTIG analyst Gregory Lewis</a> initiated coverage on the stock with a Buy rating and a price target of $55 on Oct. 9. This analyst has an accuracy rate of 75%.</li>
<li>DA Davidson analyst Michael Shlisky maintained a Buy rating and raised the price target from $66 to $67 on Aug. 9. This analyst has an accuracy rate of 61%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58aed4dbb85e9300013bf4d5/eric-stine">Craig-Hallum analyst Eric Stine</a> maintained a Buy rating and increased the price target from $54 to $65 on May 24. This analyst has an accuracy rate of 60%.</li>
</ul>
Considering buying BLBD stock? Here&#8217;s what analysts think:
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42114009/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields</a></li>
</ul>

Earnings

BLBD

Top Wall Street Forecasters Revamp Blue Bird Price Expectations Ahead Of Q4 Earnings

B of A Securities analyst Jason Zemansky maintains Kura Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) with a Buy and lowers the price target from $36 to $29.

KURA

B of A Securities Maintains Buy on Kura Oncology, Lowers Price Target to $29

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the industrials sector.
<h3 class="wp-block-heading">MSC Industrial Direct Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSM#NYSE">MSM</a>)</h3>
<ul>
<li>Dividend Yield: 4.04%</li>
<li>Baird analyst David Manthey maintained a Neutral rating and raised the price target from $84 to $91 on Oct. 16. This analyst has an accuracy rate of 82%.</li>
<li>Loop Capital analyst Chris Dankert maintained a Hold rating and cut the price target from $80 to $75 on July 3. This analyst has an accuracy rate of 78%.</li>
<li>Recent News: On Oct. 24, MSC Industrial Direct Company reported fourth-quarter results. Net sales declined 8.0% year-over-year to $952.3 million, missing the consensus of $959.7 million..</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1">latest MSM news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="892" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074709/image-242.png" alt="" class="wp-image-660841" style="width:725px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074709/image-242.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074709/image-242-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074709/image-242-768x721.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure>
<h3 class="wp-block-heading">Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>)</h3>
<ul>
<li>Dividend Yield: 3.74%</li>
<li>Morgan Stanley analyst Chris Snyder maintained an Equal-Weight rating and cut the price target from $107 to $98 on Oct. 30. This analyst has an accuracy rate of 74%.</li>
<li>Goldman Sachs analyst Joe Ritchie maintained a Neutral rating and raised the price target from $94 to $107 on Oct. 10. This analyst has an accuracy rate of 75%.</li>
<li>Recent News: On Nov. 20, Stanley Black &amp; Decker issued a strategic update, reaffirming its FY24 earnings guidance of $3.90-$4.30 per share.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1">latest SWK news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="898" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074755/image-243.png" alt="" class="wp-image-660844" style="width:665px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074755/image-243.png 898w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074755/image-243-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074755/image-243-768x714.png 768w" sizes="(max-width: 898px) 100vw, 898px" /></a></figure>
<h3 class="wp-block-heading">United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>)</h3>
<ul>
<li>Dividend Yield: 4.96%</li>
<li>Citigroup analyst Ariel Rosa maintained a Buy rating and cut the price target from $163 to $158 on Nov. 12. This analyst has an accuracy rate of 76%.</li>
<li>JP Morgan analyst Brian Osssenbeck maintained a Neutral rating and cut the price target from $140 to $139 on Oct. 25. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On Oct. 24, United Parcel Service reported better-than-expected third-quarter financial results.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1">UPS stock</a>. </li>
</ul>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="481" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074858/image-244-1024x481.png" alt="" class="wp-image-660848" style="width:645px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074858/image-244-1024x481.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074858/image-244-300x141.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074858/image-244-768x361.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074858/image-244-1536x721.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22074858/image-244.png 1842w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42131399/dow-surges-over-450-points-investor-sentiment-improves-fear-greed-index-moves-to-greed-zone">Dow Surges Over 450 Points As Nvidia Climbs Post-Earnings, Google, Amazon Slip: Fear Index Shifts To &#8216;Greed&#8217; Zone</a></li>
</ul>

Dividends

Wall Street's Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields

JMP Securities analyst Patrick Walravens maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Market Outperform and raises the price target from $342 to $450.

JMP Securities Maintains Market Outperform on Salesforce, Raises Price Target to $450

B of A Securities analyst Koji Ikeda maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Neutral and raises the price target from $94 to $120.

ESTC

B of A Securities Maintains Neutral on Elastic, Raises Price Target to $120

FLEX

Flex Announced That Kevin S. Krumm Will Join The Company As Chief Financial Officer Effective January 6, He Will Succeed Jaime Martinez, Interim CFO

B of A Securities analyst Wamsi Mohan maintains NetApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) with a Underperform and raises the price target from $115 to $121.

NTAP

B of A Securities Maintains Underperform on NetApp, Raises Price Target to $121

As Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rapidly approaches the $100,000 milestone, experts tell Benzinga its dominance is about to hit a <a href="https://www.benzinga.com/money/bitcoin-price-prediction">crucial turning point</a>. 
They attribute this rise to record-breaking trading volumes, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42042019/bitcoin-buyer-spree-microstrategy-acquires-4-6b-in-btc-metaplanet-issues-11-4m-in-bonds-to-fund-purchases">increasing institutional adoption</a> and a shift in investor focus toward <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42121936/bitcoin-boom-20-microstrategy-gains-traction-as-a-leveraged-bet-on-crypto-growth">Bitcoin as a quality asset</a>.
What Happened: Bitcoin is trading just below $99,000 at the time of writing, after hitting a record high of $99,486 late Thursday, according to <a href="https://www.coingecko.com/en/coins/bitcoin">data </a>from CoinGecko.
In a note sent to Benzinga, Sumit Gupta, co-founder of CoinDCX pointed to the sharp increase in trading activity as a major driver, with daily spot trading volumes exceeding $25 billion and peaking above $40 billion, a significant rise from the $10-12 billion seen just months ago.
&#8220;The surge has been further fueled by developments in the U.S. political landscape. Digital assets have already benefitted from the incoming administration of President-elect (Donald) Trump, with many anticipating that his potential second term could bring more favorable regulatory policies for the crypto sector,&#8221; he said.
Speculation surrounding <a href="https://www.benzinga.com/government/regulations/24/11/42120607/gary-gensler-to-step-down-as-sec-chair-on-trumps-inauguration-day">the resignation</a> of SEC Chair Gary Gensler and the potential for more <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42131449/with-gary-gensler-preparing-to-quit-in-2025-secs-crypto-cases-likely-to-quietly-go-away-amid-trumps-pro-bitcoin-stance-says-pantera-capitals-katrina-paglia">crypto-friendly leadership</a> has further boosted investor sentiment, he added.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42121525/microstrategy-surges-674-in-2024-5-etfs-that-benefit-from-mstrs-bitcoin-driven-growth">MicroStrategy Surges 674% In 2024: 5 ETFs That Benefit From MSTR&#8217;s Bitcoin-Driven Growth</a>
Avinash Shekhar, co-founder and CEO of Pi42, said Bitcoin now accounts for 58% of the total cryptocurrency market cap, which has surged to $3.2 trillion. 
"As we approach this critical milestone, the market's focus is shifting toward BTC as the dominant force," Shekhar added.
According to 10x Research, robust liquidity inflows remain a key factor driving Bitcoin's rise.
Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) and Circle (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) minted $10 billion and $3 billion respectively in the past month, contributing to an overall minting impulse of $7 billion on a 7-day rolling basis.
"This relentless liquidity is a major driver of the crypto market's momentum," the firm noted. 
Analysts at 10x Research believe that Bitcoin could reach $115,000 by Christmas, with December's historical average return of +9.1% providing a strong basis for further gains. 
"Bitcoin's upward momentum could continue well beyond the $100,000 milestone," the report concluded.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42121376/strategic-bitcoin-reserve-wouldnt-require-new-taxpayer-dollars-says-sen-cynthia-lummis">Strategic Bitcoin Reserve Wouldn&#8217;t Require New Taxpayer Dollars, Says Sen. Cynthia Lummis</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$USDC

$USDT

Bitcoin Nears $100,000, 'Momentum Could Continue Well Beyond The Milestone,' Experts Note

REPL: 26% &#x7C; <a href="https://www.benzinga.com//node/42124503">Replimune Group shares are trading higher after the company announced it received breakthrough therapy designation status for RP1 and will submit an RP1 biologics license application to the FDA under an accelerated approval pathway.</a>
&nbsp;
GAP: 16% &#x7C; <a href="https://www.benzinga.com//node/42123922">Gap shares are trading higher after the company reported better-than-expected Q3 EPS and sales.</a>
&nbsp;
KSCP: -38% &#x7C; <a href="https://www.benzinga.com//node/42125068">Knightscope shares are trading lower after the company announced a proposed public offering of Class A common stock and pre-funded warrants to address working capital needs.</a>

Movers

KSCP

REPL

Market-Moving News for November 22nd

JMP Securities analyst Patrick Walravens maintains DocuSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) with a Market Outperform and raises the price target from $84 to $108.

DOCU

JMP Securities Maintains Market Outperform on DocuSign, Raises Price Target to $108

B of A Securities analyst Jason Kupferberg maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Buy and raises the price target from $50 to $74.

AFRM

B of A Securities Maintains Buy on Affirm Holdings, Raises Price Target to $74

WIIM

ROST

Ross Stores shares are trading higher after the company reported better-than-expected Q3 EPS results.

IES Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) reported quarterly earnings of $2.79 per share. This is a 60.34 percent increase over earnings of $1.74 per share from the same period last year. The company reported $776.00 million in sales this quarter. This is a 19.57 percent increase over sales of $649.00 million the same period last year.

IESC

IES Hldgs Q4 Adj EPS $2.79 Up From $1.74 YoY, Sales $776.00M Up From $649.00M YoY

B of A Securities maintains Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) with a Neutral and raises the price target from $25 to $28.

B of A Securities Maintains Neutral on Gap, Raises Price Target to $28

Leerink Partners analyst David Risinger upgrades AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) from Market Perform to Outperform and announces $206 price target.

ABBV

Leerink Partners Upgrades AbbVie to Outperform, Announces $206 Price Target

B of A Securities analyst Tyler DuPont initiates coverage on Kyndryl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) with a Buy rating and announces Price Target of $40.

Initiation

B of A Securities Initiates Coverage On Kyndryl Hldgs with Buy Rating, Announces Price Target of $40

INTU

Intuit shares are trading lower after the company reported Q2 financial results. The company issued Q2 adjusted EPS and revenue guidance below analyst estimates.

B of A Securities analyst Tyler DuPont initiates coverage on Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) with a Neutral rating and announces Price Target of $29.

DAVA

B of A Securities Initiates Coverage On Endava with Neutral Rating, Announces Price Target of $29

Nutriband stock climbs on receiving first order for sports brand licensee Fit for Life Group

Nutriband signs exclusive supplier agreement with Fit for Life

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nutriband (NASDAQ:<a href="https://investorplace.com/stock-quotes/ntrb-stock-quote/">NTRB</a>) just reported results for the fourth quarter of 2023.<ul><li>Nutriband reported earnings per share of -23 cents.</li><li>The company reported revenue of $524,613.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/ntrb-stock-earnings-nutriband-for-q4-of-2023/">NTRB Stock Earnings: Nutriband Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

NTRB Stock Earnings: Nutriband Reported Results for Q4 2023

NTRB, AERT and SPWR among mid-day movers

GoodRx Holdings, Seelos Therapeutics, Clever Leaves among healthcare movers

Nutriband Inc (NTRB) has shared an announcement. Sergei Glinka, with a wealth of experience in the commercial sector, has been appointed as a new d...

Nutriband Inc Bolsters Board with Experienced Commercial Director

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nutriband (NASDAQ:<a href="https://investorplace.com/stock-quotes/ntrb-stock-quote/">NTRB</a>) just reported results for the first quarter of 2024.<ul><li>Nutriband reported earnings per share of -21 cents.</li><li>The company reported revenue of $408,532.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/ntrb-stock-earnings-nutriband-for-q1-of-2024/">NTRB Stock Earnings: Nutriband Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

NTRB Stock Earnings: Nutriband Reported Results for Q1 2024

An update from Nutriband ( ($NTRB) ) is now available. Nutriband Inc. has unveiled a plan to repurchase up to $1 million of its own common stock, s...

Nutriband Announces Stock Buyback and Advances in Fentanyl Patch Development

It seems time for the Securities and Exchange Commission to oversee stock advertising and consider a ban, or at least a danger warning label.

Are Pharma Stocks Harmful To Your Financial Health ?

Nutriband ( ($NTRB) ) has issued an announcement. Nutriband Inc. has secured a full patent from the Chinese National Intellectual Property Administ...

Nutriband Secures Chinese Patent for AVERSA™ Technology

AERT

ATNF

BIAF

CELC

CELZ

CLVR

EYEN

GDRX

INVO

NTRB

OMER

SEEL

SPWR

Press Releases

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Nutriband Inc. Authorizes $1M Share Buyback Program

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Comments

Nutriband

Nutriband (NTRB) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO